Inventor · Paris, FR

Daniel Gillet

11Patents
2h-index
25Co-inventors
54Inventor score

Filing activity: Apr 30, 1992 → Nov 28, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US5362644A Hybrid proteins between an extracytoplasmic enzyme and at least another protein, method for preparing them and also their applications Emerging Cross-Sectional Technologies 6 Expired
US5534223A Hybrid proteins between an extracytoplasmic enzyme and at least another protein, method for preparing them and also their applications Emerging Cross-Sectional Technologies 5 Expired
US9598406B2 Quinazolinone derivatives for use in the treatment of chlamydiales infections Chemistry; Metallurgy 1 Active
US9034868B2 Inhibitors of the shiga toxins trafficking through the retrograde pathway Emerging Cross-Sectional Technologies 1 Active
US9540356B2 Compounds having a protective activity against toxins with intracellular activity Chemistry; Metallurgy 1 Active
US8609732B2 Inhibitors of the Shiga toxins trafficking through the retrograde pathway Emerging Cross-Sectional Technologies 1 Active
US9758552B2 HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway Chemistry; Metallurgy 0 Active
US12024508B2 Dihydroquinazolinones exhibiting protective activity against intracellular-acting toxins, intracellular viruses and bacteria Emerging Cross-Sectional Technologies 0 Active
US9675615B2 2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections Chemistry; Metallurgy 0 Active
US11136299B2 Benzodiazepine derivatives for use in the treatment of Chlamydiales infections Human Necessities 0 Active
US10039727B2 Adamantane or pinene derivatives for use in the treatment of chlamydiales infections Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.